Defender Capital, Llc. Athenex, Inc. Transaction History

Defender Capital, Llc.

  • $288 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022
SELL
$0.79 - $1.59 $16,195 - $32,595
-20,500 Closed
0 $0
Q4 2021

Feb 01, 2022
BUY
$1.36 - $2.94 $680 - $1,470
500 Added 2.5%
20,500 $28,000
Q1 2021

Apr 20, 2021
BUY
$4.08 - $14.75 $81,600 - $295,000
20,000 New
20,000 $86,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Defender Capital, Llc. Portfolio

Follow Defender Capital, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Defender Capital, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Defender Capital, Llc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email